Understanding Type 1 Diabetes

Category: Education

ASO Keyword Dashboard

Tracking 18 keywords for Understanding Type 1 Diabetes in Apple App Store

Developer: Med Learning Group Category: education

Understanding Type 1 Diabetes tracks 18 keywords (2 keywords rank; 16 need traction). Key metrics: 0% top-10 coverage, opportunity 52.0, difficulty 38.9, best rank 12.

Tracked keywords

2 ranked • 16 not ranking yet

Top 10 coverage

Best rank 12 • Latest leader 39

Avg opportunity

52.0

Top keyword: understand

Avg difficulty

38.9

Lower scores indicate easier wins

Opportunity leaders

understand

Opportunity: 58.0 • Difficulty: 44.4 • Rank 39

Competitors: 142
65.4
mobile

Opportunity: 58.0 • Difficulty: 60.2 • Rank —

Competitors: 846
81.3
tool

Opportunity: 58.0 • Difficulty: 46.5 • Rank —

Competitors: 170
69.1
type

Opportunity: 58.0 • Difficulty: 46.1 • Rank —

Competitors: 166
65.2
well

Opportunity: 58.0 • Difficulty: 49.3 • Rank —

Competitors: 296
72.1

Unranked opportunities

mobile

Opportunity: 58.0 • Difficulty: 60.2 • Competitors: 846
tool

Opportunity: 58.0 • Difficulty: 46.5 • Competitors: 170
type

Opportunity: 58.0 • Difficulty: 46.1 • Competitors: 166
well

Opportunity: 58.0 • Difficulty: 49.3 • Competitors: 296
enhanced

Opportunity: 58.0 • Difficulty: 44.4 • Competitors: 115

High competition keywords

mobile

Total apps: 3,947 • Major competitors: 846

Latest rank: — • Difficulty: 60.2
well

Total apps: 1,543 • Major competitors: 296

Latest rank: — • Difficulty: 49.3
tool

Total apps: 1,134 • Major competitors: 170

Latest rank: — • Difficulty: 46.5
understand

Total apps: 776 • Major competitors: 142

Latest rank: 39 • Difficulty: 44.4
type

Total apps: 765 • Major competitors: 166

Latest rank: — • Difficulty: 46.1

All tracked keywords

Includes opportunity, difficulty, rankings and competitor benchmarks

							Major Competitors
understanding	57	100	37	55 266 competing apps Median installs: 199,150 Avg rating: 4.6	12	12	39 major competitor apps
understand	58	100	44	65 776 competing apps Median installs: 244,462 Avg rating: 4.6	39	39	142 major competitor apps
mobile	58	100	60	81 3,947 competing apps Median installs: 251,675 Avg rating: 4.7	—	—	846 major competitor apps
stage	57	100	37	54 246 competing apps Median installs: 239,225 Avg rating: 4.6	—	—	52 major competitor apps
tool	58	100	47	69 1,134 competing apps Median installs: 210,275 Avg rating: 4.6	—	—	170 major competitor apps
type	58	100	46	65 765 competing apps Median installs: 272,225 Avg rating: 4.6	—	—	166 major competitor apps
monitoring	57	100	44	55 258 competing apps Median installs: 212,525 Avg rating: 4.6	—	—	47 major competitor apps
well	58	100	49	72 1,543 competing apps Median installs: 241,700 Avg rating: 4.6	—	—	296 major competitor apps
reality	57	100	38	53 231 competing apps Median installs: 285,900 Avg rating: 4.6	—	—	53 major competitor apps
early	20	100	50	60 448 competing apps Median installs: 310,325 Avg rating: 4.7	—	—	122 major competitor apps
importance	57	100	25	38 48 competing apps Median installs: 184,062 Avg rating: 4.6	—	—	9 major competitor apps
enhanced	58	100	44	61 506 competing apps Median installs: 275,812 Avg rating: 4.6	—	—	115 major competitor apps
treatment	57	100	32	48 131 competing apps Median installs: 188,575 Avg rating: 4.6	—	—	26 major competitor apps
detection	57	100	40	51 187 competing apps Median installs: 261,525 Avg rating: 4.5	—	—	37 major competitor apps
screening	56	100	21	32 25 competing apps Median installs: 204,600 Avg rating: 4.6	—	—	3 major competitor apps
diabetes	57	100	28	37 44 competing apps Median installs: 214,138 Avg rating: 4.5	—	—	8 major competitor apps
overviews	56	90	49	25 12 competing apps Median installs: 339,312 Avg rating: 4.7	—	—	3 major competitor apps
considerations	0	26	9	14 3 competing apps Median installs: 204,950 Avg rating: 4.6	—	—	0 major competitor apps

App Description

This tool is an enhanced reality mobile application that overviews the importance of screening and early detection of type 1 diabetes (T1D), as well as considerations for monitoring and treatment of early-stage T1D.